跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Spesolimab Injection (Subcutaneous Injection)
Approved
生物制品
Spesolimab Injection (Subcutaneous Injection)
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
Mar 5, 2024
Approval ID
8YF466rxIby
Company
Boehringer Ingelheim International GmbH
Type
生物制品
Approval Details
Approval Id
8YF466rxIby
Approval Number
国药准字SJ20240012
Generic Name
佩索利单抗注射液(皮下注射)
Generic Name En
Spesolimab Injection (Subcutaneous Injection)
Trade Name
斯全诺
Drug Type
生物制品
Dosage Form
注射剂
Strength
预充式注射器注射剂型:150mg(1mL)/支
Reg Date
2024-03-05
Expired Date
2029-03-04
Company Name
Boehringer Ingelheim International GmbH
Production Company Name
Boehringer Ingelheim Pharma GmbH & Co. KG
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Production Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 5, 2024
Approval ID
8YF466rxIby
Type
生物制品
Back to NMPA Approvals
斯全诺 - NMPA Drug Approval Details